Research map: National guideline for hepatitis B elimination in Thailand: a decentralized health system model for expanding diagnosis and treatment

Back to the article

Papers in this map

  1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries · Hyuna Sung · 2021 · 114646 citations · Cited by this paper
  2. Clinical trial endpoints for metabolic dysfunction and alcohol associated steatotic liver disease · 2026 · Related
  3. Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level · Chien‐Jen Chen · 2006 · 3162 citations · Cited by this paper
  4. APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update · 2026 · Related
  5. Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update · Masao Omata · 2017 · 2209 citations · Cited by this paper
  6. APASL STC on Wilson Disease; New Delhi 2026 · 2026 · Related
  7. Global burden of primary liver cancer in 2020 and predictions to 2040 · Harriet Rumgay · 2022 · 2199 citations · Cited by this paper
  8. Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial · 2026 · Related
  9. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma · Amit G. Singal · 2023 · 1950 citations · Cited by this paper
  10. Phosphatidylethanol versus clinical criteria to diagnose alcohol use relapse after liver transplantation: a prospective cohort study · 2026 · Related
  11. Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load · Uchenna H. Iloeje · 2006 · 1542 citations · Cited by this paper
  12. Precision medicine for G-CSF in ACLF: the biomarker gap · 2026 · Related
  13. Randomized controlled trial of screening for hepatocellular carcinoma · Boheng Zhang · 2004 · 1503 citations · Cited by this paper
  14. Response to letter to editor—Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon · 2026 · Related
  15. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis · Kristina Tzartzeva · 2018 · 1207 citations · Cited by this paper
  16. Methodological Considerations in the MAFLD-MASLD Dichotomy for Cardiac Risk Assessment · 2026 · Related
  17. Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis · Amit G. Singal · 2014 · 833 citations · Cited by this paper
  18. Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis · 2026 · Related
  19. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load · Calvin Q. Pan · 2016 · 585 citations · Cited by this paper
  20. Guidelines for the Prevention, Diagnosis, Care and Treatment for People with Chronic Hepatitis B Infection (Text Extract): Executive Summary. · 2025 · Related
  21. Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma · Hwai‐I Yang · 2008 · 584 citations · Cited by this paper
  22. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial · Marı́a Buti · 2016 · 558 citations · Cited by this paper
  23. Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy · George Papatheodoridis · 2015 · 512 citations · Cited by this paper
  24. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial · Henry Lik‐Yuen Chan · 2016 · 469 citations · Cited by this paper
  25. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection · Markus Cornberg · 2025 · 420 citations · Cited by this paper
  26. Advances in non-invasive assessment of hepatic fibrosis · Rohit Seth Loomba · 2020 · 345 citations · Cited by this paper
  27. Carriers of Inactive Hepatitis B Virus Are Still at Risk for Hepatocellular Carcinoma and Liver-Related Death · Jin–De Chen · 2010 · 334 citations · Cited by this paper
  28. Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen–negative chronic hepatitis B · Wen‐Juei Jeng · 2017 · 330 citations · Cited by this paper
  29. Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study · Thomas Berg · 2017 · 320 citations · Cited by this paper
  30. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival · Valentina Santi · 2010 · 303 citations · Cited by this paper
  31. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B · Gonzague Jourdain · 2018 · 288 citations · Cited by this paper
  32. Discontinuation of oral antivirals in chronic hepatitis B: A systematic review · George Papatheodoridis · 2016 · 281 citations · Cited by this paper
  33. Natural history of chronic hepatitis B REVEALed · Chien‐Jen Chen · 2011 · 278 citations · Cited by this paper
  34. Universal health coverage and primary care, Thailand · Kanitsorn Sumriddetchkajorn · 2019 · 213 citations · Cited by this paper
  35. Progress towards elimination goals for viral hepatitis · Andrea L. Cox · 2020 · 208 citations · Cited by this paper
  36. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis · Anna Louise Funk · 2020 · 206 citations · Cited by this paper
  37. Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023 · Juan Ambrosioni · 2023 · 187 citations · Cited by this paper
  38. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis · Marcus Maximilian Mücke · 2018 · 176 citations · Cited by this paper
  39. Global wage report 2024-25 · 2024 · 175 citations · Cited by this paper

Source: OpenAlex (CC0)